MicroRNA Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. Rising prevalence of chronic and acute disease is a key factor driving the global microRNA market, says Fortune Business Insights in a report, titled “MicroRNA Market Size, Share and Global Trend By Type (Product, Services miRNA cDNA Synthesis, miRNA Profiling & Purification, Next Generation Sequencing, Detection, miRNA Functional Studies, Micro Assays), By Application (Cancer, Cardiovascular Disease, Infectious Disease, Inherited Disease) By End User (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes) and Geography Forecast till 2026.” Rising demand for preventive care is expected to promote the growth of the global microRNA market.
Rising Awareness Regarding Microrna Therapeutics Will Enable Growth
The rising investments in research & development activities and is expected to support the growth of the global microRNA market. The increasing prevalence of chronic and acute diseases around the world is likely to boost the global microRNA market revenue during the forecast period. Furthermore, the unveiling of preclinical data in pulmonary fibrosis is expected to augment the growth of the global microRNA market. For instance, miRagen Therapeutics presented preclinical data in pulmonary fibrosis with the usage of second-generation microRNA-29 replacement product candidate at the 2019 American Thoracic Society’s International Conference. In addition, rising awareness regarding MicroRNA therapeutics along with increasing geriatric population is predicted to contribute significantly to the global microRNA market.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/microrna-market-101237
The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global MicroRNA market and discusses how major companies are coping with this.
Key Players Operating in The MicroRNA Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Merck Sharp & Dohme Corp.
- QIAGEN, Dharmacon
- Thermo Fisher Scientific
- Synlogic, GeneCopoeia, Inc.
- New England Biolabs
- Regulus Therapeutics Inc.
- NanoString Technologies, Inc.
- and BioGenex
- and other players.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microrna-market-101237
Increasing Demand for Preventive Care Will Boost Growth
The dynamic and transformative nature of MicroRNA therapeutics is likely to duel demand, which, will, in, turn aid growth of the global microRNA market. The rising demand for preventive care is also likely to enable growth of the global microRNA market. Furthermore, the launch of RG-012 by Regulus Therapeutics Inc. is expected to escalate the global microRNA market shares. For instance, Regulus Therapeutics Inc. announced that their MicroRNA Therapeutic candidate called RG-012 for the Alport syndrome is on track as planned and was at the stage of initiation for Phase II clinical trials
Key questions answered in the report:
- What will the market growth rate of MicroRNA market in 2027?
- What are the key factors driving the global MicroRNA market?
- Who are the key manufacturers in MicroRNA market space?
- What are the market opportunities, market risk and market overview of the MicroRNA market?
- What are sales, revenue, and price analysis of top manufacturers of MicroRNA market?
- Who are the distributors, traders and dealers of MicroRNA market?
- What are the MicroRNA market opportunities and threats faced by the vendors in the global MicroRNA industry?
- What are sales, revenue, and price analysis by types and applications of MicroRNA market?
- What are sales, revenue, and price analysis by regions of MicroRNA industry?
North America to Remain Dominant; Increasing Number of Clinical Trials to Accelerate Growth
Among all the regions, North America is expected to remain at the forefront and hold the highest position in the global miRNA market in the forthcoming years. This is attributable to the increasing microRNA clinical trials to develop advanced diagnostic solutions in countries such as the U.S. North America stood at USD 97.4 million in 2019.
On the other hand, Europe is expected to hold the second position in the market in the forthcoming years. This is ascribable to factors such as growing government funding for the startups for R&D activities to develop novel microRNA-based therapies and gain valuable insights in the molecular diagnostics in the region.
Partnership Among Key Players to Develop Advanced Treatment Solutions
The global microRNA market is fragmented by the presence of major companies that are focusing on partnering with other like-minded companies to develop novel microRNA-based treatment solutions on account of the increasing prevalence of chronic diseases. Moreover, other key players are striving to maintain their position by adopting strategies such as merger and acquisition, facility expansion, and collaboration that is likely to favor the growth of the market during the forecast period.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/microrna-market-101237
Table of Content:
1 MicroRNA Market Overview
1.1 MicroRNA Product Overview
1.2 MicroRNA Market Segment by Type
1.3 Global MicroRNA Market Size by Type (2015-2027)
1.3.1 Global MicroRNA Market Size Overview by Type (2015-2027)
1.3.2 Global MicroRNA Historic Market Size Review by Type (2015-2021)
184.108.40.206 Global MicroRNA Sales Market Share Breakdown by Type (2015-2027)
220.127.116.11 Global MicroRNA Market Share Breakdown by Type (2015-2027)
18.104.22.168 Global MicroRNA Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global MicroRNA Market Size Forecast by Type (2021-2027)
22.214.171.124 Global MicroRNA Sales Market Share Breakdown by Application (2021-2027)
126.96.36.199 Global MicroRNA Revenue Market Share Breakdown by Application (2021-2027)
188.8.131.52 Global MicroRNA Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America MicroRNA Sales Breakdown by Type (2015-2027)
1.4.2 Europe MicroRNA Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific MicroRNA Sales Breakdown by Type (2015-2027)
1.4.4 Latin America MicroRNA Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa MicroRNA Sales Breakdown by Type (2015-2027)
2 Global MicroRNA Market Competition by Company
2.1 Global Top Players by MicroRNA Sales (2015-2021)
2.2 Global Top Players by MicroRNA Revenue (2015-2021)
2.3 Global Top Players MicroRNA Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company MicroRNA Manufacturing Base Distribution, Sales Area, Product Type
2.5 MicroRNA Market Competitive Situation and Trends
2.5.1 MicroRNA Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by MicroRNA Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MicroRNA as of 2019)
2.7 Date of Key Company Enter into MicroRNA Market
2.8 Key Company MicroRNA Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global MicroRNA Status and Outlook by Region (2015-2027)
3.1 Global MicroRNA Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global MicroRNA Market Size Market Share by Region (2015-2021)
3.2.1 Global MicroRNA Sales Market Share by Region (2015-2021)
3.2.2 Global MicroRNA Revenue Market Share by Region (2015-2021)
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245